vs
Side-by-side financial comparison of ASCENT INDUSTRIES CO. (ACNT) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
Spero Therapeutics, Inc. is the larger business by last-quarter revenue ($12.6M vs $11.9M, roughly 1.1× ASCENT INDUSTRIES CO.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs -8.8%, a 259.4% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 13.3%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs -34.9%).
ASCENT INDUSTRIES CO.ACNTEarnings & Financial Report
Ascent Capital Group, Inc. was a publicly traded holding company whose primary subsidiary was Monitronics. Ascent Media was a wholly owned subsidiary of the Discovery Holding Company (DHC). DHC spun off Ascent Media as an independent, public company on September 17, 2008.
ACNT vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.9M | $12.6M |
| Net Profit | $-1.0M | $31.5M |
| Gross Margin | 14.6% | — |
| Operating Margin | -21.0% | — |
| Net Margin | -8.8% | 250.7% |
| Revenue YoY | 13.3% | 24080.8% |
| Net Profit YoY | -1.2% | 250.9% |
| EPS (diluted) | $-0.11 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.9M | $12.6M | ||
| Q3 25 | $19.7M | $0 | ||
| Q2 25 | $18.7M | $0 | ||
| Q1 25 | $24.7M | $12.0K | ||
| Q4 24 | $10.5M | $52.0K | ||
| Q3 24 | $20.9M | $65.0K | ||
| Q2 24 | $21.5M | $114.0K | ||
| Q1 24 | $28.0M | $140.0K |
| Q4 25 | $-1.0M | $31.5M | ||
| Q3 25 | $-2.1M | $-7.4M | ||
| Q2 25 | $6.3M | $-1.7M | ||
| Q1 25 | $-2.3M | $-13.9M | ||
| Q4 24 | $-1.0M | — | ||
| Q3 24 | $-6.2M | $-17.1M | ||
| Q2 24 | $-926.0K | $-17.9M | ||
| Q1 24 | $-5.5M | $-12.7M |
| Q4 25 | 14.6% | — | ||
| Q3 25 | 29.7% | — | ||
| Q2 25 | 26.1% | — | ||
| Q1 25 | 19.3% | — | ||
| Q4 24 | 24.3% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 13.1% | — | ||
| Q1 24 | 8.3% | — |
| Q4 25 | -21.0% | — | ||
| Q3 25 | -4.1% | — | ||
| Q2 25 | -14.4% | — | ||
| Q1 25 | -4.2% | -122758.3% | ||
| Q4 24 | -25.4% | — | ||
| Q3 24 | -9.4% | -28604.6% | ||
| Q2 24 | -8.6% | -16720.2% | ||
| Q1 24 | -15.5% | -9987.1% |
| Q4 25 | -8.8% | 250.7% | ||
| Q3 25 | -10.6% | — | ||
| Q2 25 | 33.7% | — | ||
| Q1 25 | -9.3% | -115550.0% | ||
| Q4 24 | -9.8% | — | ||
| Q3 24 | -29.5% | -26380.0% | ||
| Q2 24 | -4.3% | -15668.4% | ||
| Q1 24 | -19.7% | -9049.3% |
| Q4 25 | $-0.11 | $0.56 | ||
| Q3 25 | $-0.22 | $-0.13 | ||
| Q2 25 | $0.65 | $-0.03 | ||
| Q1 25 | $-0.23 | $-0.25 | ||
| Q4 24 | $-0.11 | — | ||
| Q3 24 | $-0.61 | $-0.32 | ||
| Q2 24 | $-0.09 | $-0.33 | ||
| Q1 24 | $-0.54 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $57.6M | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $87.0M | $59.0M |
| Total Assets | $111.9M | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $57.6M | $40.3M | ||
| Q3 25 | $58.0M | $48.6M | ||
| Q2 25 | $60.5M | $31.2M | ||
| Q1 25 | $14.3M | $48.9M | ||
| Q4 24 | $16.1M | $52.9M | ||
| Q3 24 | $8.5M | $76.3M | ||
| Q2 24 | $3.6M | $63.5M | ||
| Q1 24 | $1.3M | $82.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $87.0M | $59.0M | ||
| Q3 25 | $87.1M | $26.5M | ||
| Q2 25 | $89.7M | $32.8M | ||
| Q1 25 | $91.2M | $33.8M | ||
| Q4 24 | $93.5M | $46.1M | ||
| Q3 24 | $94.7M | $65.5M | ||
| Q2 24 | $101.0M | $80.5M | ||
| Q1 24 | $102.0M | $96.2M |
| Q4 25 | $111.9M | $68.9M | ||
| Q3 25 | $119.9M | $54.2M | ||
| Q2 25 | $122.6M | $62.1M | ||
| Q1 25 | $152.5M | $77.7M | ||
| Q4 24 | $147.3M | $110.5M | ||
| Q3 24 | $148.6M | $135.2M | ||
| Q2 24 | $158.2M | $149.9M | ||
| Q1 24 | $161.0M | $167.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $266.0K | $-8.4M |
| Free Cash FlowOCF − Capex | $-196.0K | — |
| FCF MarginFCF / Revenue | -1.7% | — |
| Capex IntensityCapex / Revenue | 3.9% | — |
| Cash ConversionOCF / Net Profit | — | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | $-2.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $266.0K | $-8.4M | ||
| Q3 25 | $1.3M | $17.4M | ||
| Q2 25 | $-1.4M | $-17.7M | ||
| Q1 25 | $-700.0K | $-4.0M | ||
| Q4 24 | $8.8M | $-23.4M | ||
| Q3 24 | $3.4M | $12.8M | ||
| Q2 24 | $2.2M | $-18.7M | ||
| Q1 24 | $263.0K | $5.9M |
| Q4 25 | $-196.0K | — | ||
| Q3 25 | $695.0K | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-1.0M | — | ||
| Q4 24 | $8.4M | — | ||
| Q3 24 | $3.1M | — | ||
| Q2 24 | $1.9M | — | ||
| Q1 24 | $25.0K | — |
| Q4 25 | -1.7% | — | ||
| Q3 25 | 3.5% | — | ||
| Q2 25 | -8.3% | — | ||
| Q1 25 | -4.1% | — | ||
| Q4 24 | 80.6% | — | ||
| Q3 24 | 15.1% | — | ||
| Q2 24 | 9.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | 3.9% | — | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 3.7% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | — | -0.26× | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.22× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACNT
| Other | $6.1M | 52% |
| Transferred At Point In Time | $5.7M | 48% |
SPRO
Segment breakdown not available.
